Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Not yet recruiting × Myasthenia Gravis × rozanolixizumab × Clear all

Phase

Status

Completed 4 Recruiting 2 Not yet recruiting 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Myasthenia Gravis 2

Interventions

telitacicept 3 rozanolixizumab 2 Prednisone 2 ravulizumab 1 fludarabine 1 blinatumomab 1 Pyridostigmine Bromide 1 Psychodrama 1 Prednisolone 1 Population Groups 1 Cyclophosphamide 1 Art Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07463521 2026-03-17

MyVision

UCB Pharma

Phase 3 Not yet recruiting

Myasthenia Gravis

NCT07465289 2026-03-11

A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

UCB Pharma

Phase 3 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡